The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|December 1, 2000
Supplements and Featured Publications
- New Approaches for the Diagnosis and Management of Alzheimer's Disease
- Volume 6
- Issue 22 Suppl
Selected Abstracts
Advertisement
Articles in this issue
almost 26 years ago
Participating Facultyalmost 26 years ago
Introductionalmost 26 years ago
Screening and Early Diagnosis of Dementiaalmost 26 years ago
Alzheimer's Disease: Clinical Treatment Optionsalmost 26 years ago
The Pharmacoeconomics of Alzheimer's Diseasealmost 26 years ago
Managed Care Decisions in Alzheimer's Diseasealmost 26 years ago
Continuing Medical Education QuizAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
3
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5